Michael del Aguila, PhD has joined DRE as SVP of Client Solutions and is an industry executive with over 20 years’ experience in health services research with positions in non-profit, governmental, managed care and commercial biopharma organizations. Michael holds a PhD in epidemiology from the University of Washington.
In his many leadership roles in the pharmaceutical industry, Michael has managed teams providing cross portfolio support in health economics and outcomes research, Phase 3b/4 clinical research at Roche/Genentech, and more recently Bristol-Myers Squibb. He led cross-functional teams of biostatisticians, data management, and HEOR scientists to develop and conduct research programs to support launch and medical market access activities in oncology, immunology, cardiovascular, transplant and virology. This included design, conduct and analysis of 20 clinical studies, including trials and registries, as well as other observational studies. At both Genentech and BMS, Michael was responsible for field teams of health economic liaisons who provided Medical support for payers and other customers in the US.
As Senior Director in global Pricing and Market Access at Gilead, Michael led a team of market access and pricing specialists to support the global launches of Sovaldi and Stribild and Zydelig. Previously, as Director in global strategic pricing and reimbursement at Schering Plough, Michael was responsible for coordinating submission of dossiers to NICE for Temodar, Vytorin and Remicade. Other experience includes large database analyses from managed care claims data and other healthcare data sets. Michael founded and led the Delta Dental Data Data; Analysis Center, which warehoused claims data from 8 large dental insurance companies in a consolidated data warehouse for use by managed care, pharmaceutical and academic research.